Microbot Medical (MBOT) announced that it will be exhibiting the LIBERTY System at the upcoming Symposium on Clinical Interventional Oncology annual meeting, CIO, being held in Miami, FL on October 17-19. The annual symposium presents practical education on the latest treatments in the rapidly expanding field of interventional oncology and represents the first medical meeting at which the Company will commercially exhibit the LIBERTY System following its FDA 510(k) clearance in early September of this year.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical Partners for LIBERTY System Launch
- Microbot Medical partners with 3PL company to commercialize LIBERTY System
- Microbot Medical files to sell 900,153 shares of common stock for holders
- Microbot Medical files to sell 14.69M shares of common stock for holders
- Microbot Medical Completes Final Closing of Investment Options